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Abstract
Background—As maternal fever affects approximately 6–8% of early pregnancies, it is 
important to expand upon previous observations of an association between maternal fever and 
birth defects.
Methods—We analyzed data from the National Birth Defects Prevention Study, a multistate, 
case-control study of major structural birth defects. Telephone interviews were completed by 
mothers of cases (n = 17,162) and controls (n = 10,127). Using multivariable logistic regression, 
we assessed the association between maternal self-report of cold or flu with fever and cold or flu 
without fever during early pregnancy and 30 categories of non-cardiac birth defects.
Results—Maternal report of cold or flu with fever was significantly associated with 8 birth 
defects (anencephaly, spina bifida, encephalocele, cleft lip with or without cleft palate, colonic 
atresia/stenosis, bilateral renal agenesis/hypoplasia, limb reduction defects, and gastroschisis) with 
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elevated adjusted odds ratios ranging from 1.2 to 3.7. Maternal report of cold or flu without fever 
was not associated with any of the birth defects studied.
Conclusions—This study adds to the evidence that maternal fever during early pregnancy is 
associated with an increased risk for selected birth defects. Elevated associations were limited to 
mothers who reported a fever, suggesting that it is fever that contributes to the excess risk rather 
than illnesses associated with it. However, fever may also serve as a marker for more severe 
infections.
Keywords
cold; colonic atresia; fever; flu; gastroschisis; limb reduction defects; neural tube defects; oral 
clefts; renal agenesis
1 | INTRODUCTION
The possibility of a teratogenic effect of fever was first postulated by researchers conducting 
ecologic studies of influenza and birth defects (Janerich, 1971; MacMahon & Yen, 1971). 
Stronger evidence of an association between maternal exposure to hyperthermia and an 
increased occurrence of birth defects was subsequently provided by animal studies 
(Cawdell-Smith, Upfold, Edwards, & Smith, 1992; Edwards, Shiota, Smith, & Walsh, 1995; 
Finnell, Moon, Abbott, Golden, & Chernoff, 1986) and epidemiologic studies of fever and 
neural tube defects (NTDs) (Kurppa, Holmberg, Kuosma, Aro, & Saxen, 1991; Li et al., 
2007; Lynberg, Khoury, Lu, & Cocian, 1994; Medveczky, Puho’, & Czeizel, 2004; Milunsky 
et al., 1992; Moretti, Benjamin, Fried, & Koren, 2005; Shaw, Todoroff, Velie, & Lammer, 
1998; Shaw et al., 2002; Suarez, Felkner, & Hendricks, 2004; Yin et al., 2011; Zhang and 
Cai, 1993). A recent systematic review by Dreier, Andersen, and Berg-Beckhoff (2014) 
noted that the literature supports an association between maternal fever and an increased risk 
of birth defects, with the strongest associations for NTDs, oral clefts and cardiac defects. 
However, the association with many other categories of birth defects has not been addressed 
and many of the existing studies do not distinguish between the effects of maternal fever and 
the illnesses that cause it.
Using data from the National Birth Defects Prevention Study (NBDPS), our objective was to 
determine whether maternal fever in response to a cold or flu during early pregnancy is a 
risk factor for any of 30 categories of noncardiac birth defects, independent of the 
underlying illness.
As maternal fever in early pregnancy affects approximately 6 to 8% of pregnant women in 
the United States (Dreier et al., 2014; Moretti et al., 2005), continued research in this area 
may generate findings that can be used to provide evidence-based advice to a large number 
of pregnant women and their health care providers. Also, clarification of the specific 
categories of birth defects associated with maternal fever may provide insight into 
differences in the mechanisms of teratogenicity across categories of birth defects.
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2 | MATERIALS AND METHODS
The NBDPS is a population-based, multistate, case-control study of risk factors for selected 
major structural malformations. Detailed study methods have been published previously 
(Rasmussen et al., 2003; Reefhuis et al., 2015). Cases and controls had estimated dates of 
delivery between October 1, 1997 and December 31, 2011. Cases were ascertained by 
surveillance systems at ten sites (Arkansas, California, Georgia, Iowa, Massachusetts, New 
Jersey, New York, North Carolina, Texas, and Utah). Controls were live born infants without 
birth defects, selected from birth certificates or birth hospital logs to be representative of the 
population from which the cases arose. This study was approved by the Institutional Review 
Boards of each study site and the Centers for Disease Control and Prevention.
Cases included live births, fetal deaths and pregnancy terminations. All cases were 
diagnosed by physical examination, imaging, autopsy, or pathology reports from surgical 
procedures. Case infants were aggregated across study sites and reviewed by clinical 
geneticists affiliated with the NBDPS according to established guidelines and classified as 
having isolated, multiple, or complex birth defects (Rasmussen et al., 2003). Cases with 
isolated birth defects were defined as having either one major birth defect, two or more 
major birth defects affecting only one organ system, or one major birth defect with a 
sequence of related defects. Cases with multiple birth defects had two or more major 
unrelated defects in different organ systems. Birth defects that were known or strongly 
suspected to have been caused by single-gene disorders or chromosomal abnormalities were 
excluded from the NBDPS. Utah was unable to contribute cases of orofacial clefts in 2003, 
and cases of congenital cataracts were only contributed study-wide beginning January 1, 
2000. For calculations involving these birth defects, we excluded information from controls 
for those locations and study periods during which cases were not available. Controls for 
analyses of hypospadias were restricted to male infants because all cases of hypospadias 
were male.
Maternal interviews were conducted using a standardized computer-assisted telephone 
interview, in either English or Spanish, between 6 weeks and 24 months from the estimated 
date of delivery. Participation rates were 67% for controls and 64% for cases. Interviews 
were completed within an average of 11 months from the estimated date of delivery for case 
mothers and 9 months for control mothers.
3 | EXPOSURE ASSESSMENT
A sequence of interview questions were used to obtain maternal histories of cold or flu 
before and during pregnancy. Mothers were asked whether they had “a cold or flu” during 
this time period. If they answered yes, they were asked to give the dates that the illness 
began and ended and whether they had a fever in response to it. If they could not provide 
exact dates they were allowed to report the month immediately before conception or during 
gestation that the cold or flu occurred. For each fever they were asked “what was the highest 
temperature recorded during your fever?” Mothers were also asked about fevers not related 
to cold or flu. However, in this analysis we focused exclusively on the effect of fevers in 
response to a cold or flu, which comprised 83 percent of all fevers reported.
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We assessed illnesses due to cold and flu during the 3 month time period beginning 1 month 
(30 days) prior to conception and ending 2 months (60 days) after conception. We classified 
maternal exposures that occurred during this time period into one of three categories; (1) 
maternal report of cold or flu with fever, (2) maternal report of cold or flu without fever, (3) 
no maternal report of cold or flu (referent). Mothers who reported a cold or flu outside of the 
defined time period were considered unexposed and included in the referent group. We also 
assessed whether our results for exposure to cold or flu with fever during the critical period 
changed when we stratified maternal reports of fever into three groups according to the 
mother’s report of the maximum reported temperature and compared the effect of these three 
exposure subgroups with the referent group of no fever.
4 | STATISTICAL ANALYSIS
We excluded mothers who were missing information on whether or not they had a cold or 
flu during the exposure window of interest or missing information on one or more of the 
covariates described below.
Using logistic regression, we calculated crude and adjusted ORs (cOR and aOR, 
respectively) for the association between maternal report of cold or flu with fever and 
maternal report of cold or flu without fever and 30 categories of NBDPS noncardiac birth 
defects, compared with the referent group which was comprised of mothers who gave no 
report of a cold or flu during the defined time period. As Botto et al. (2014) published results 
for the association between maternal fever and different categories of cardiac birth defects 
using the NBDPS database, we limited the current study to non-cardiac birth defects. We 
included only those categories of noncardiac birth defects for which there were at least three 
cases exposed to cold or flu with fever.
We controlled for the potential of confounding by maternal age (<18 years, 19–24 years, 25–
29 years, 30–34 years, 35–39 years, and ≥40 years), maternal race and ethnicity (non-
Hispanic White, non-Hispanic Black, Hispanic, and other race or ethnicity), maternal level 
of educational attainment (less than high school [<9 years of completed education], some 
high school [9–11 years], high school graduate [12 years], some college [13–15 years], and 
college graduate [≥16 years]), any maternal smoking between 1 month before conception 
and 3 months after conception (yes, no), maternal prepregnancy body mass index (BMI; 
<18.5 kg/m2, 18.5–24.9 kg/m2, 25.0–29.9 kg/m2, and ≥30.0 kg/m2), first live birth (yes, no), 
timing and frequency of maternal use of supplements containing folic acid (optimal intake 
daily from 1 month before conception to 1 month after conception), suboptimal intake (any 
intake during the same period), poor intake (intake beginning later than 1 month after 
conception or no intake), and study site (Arkansas, California, Georgia, Iowa, 
Massachusetts, New Jersey, New York, North Carolina, Texas, and Utah).
We also undertook five sensitivity analyses to determine whether specific changes in the 
analysis would affect our results. For each of these, we implemented a single change and 
recalculated all aORs: (a) To confirm that the effects of fever did not extend to exposures 
that occurred later than 60 days of gestation, we calculated aORs for maternal reports of 
cold or flu with fever during the 3rd or 4th month of pregnancy (61–120 days after 
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conception); (b) We calculated aORs excluding 17.5% of case mothers with infants with 
multiple or complex birth defects; (c) We calculated aORs excluding 7.0% of case and 
control mothers who reported a fever from an illness other than a cold or flu during the 
critical period from 1 month prior to conception to 2 months after conception (As we did not 
have information on the timing of fevers associated with urinary tract infection, in this step 
we excluded all fevers that were associated with a UTI, irrespective of their timing); (d) We 
calculated aORs excluding 2.0% of case and control mothers with pre-existing Type I or 
Type II diabetes mellitus; (e) As use of aspirin or ibuprofen during early pregnancy is 
associated with some categories of birth defects (Hernandez et al., 2012) we calculated 
aORs excluding 28.4% of case and control mothers who took these medications during the 
critical period from 1 month before conception to 2 months after conception. As a previous 
NBDPS analysis found no association between use of acetaminophen during early 
pregnancy and the birth defects that we studied, we did not run analyses excluding mothers 
who took acetaminophen during the critical period (Feldkamp, Meyer, Krikov, & Botto, 
2010).
5 | RESULTS
After excluding 9.4% of study participants that were missing information on whether or not 
they had a cold or flu during the exposure window of interest and 6.6% who were missing 
information on one or more of the covariates, 17,162 cases mothers and 10,127 control 
mothers remained in our analysis.
Case and control mothers were similar with respect to use of supplements containing folic 
acid (Table 1). Case mothers were slightly more likely to be younger than 25 or older than 
40 years of age, smokers, obese, having their first live birth or having attained less than a 
high school education. Case mothers were slightly less likely to be college graduates or of 
non-Hispanic Black race/ethnicity (Table 1).
We assessed the percentage of mothers that reported a cold or flu during the exposure 
period, separately by the 30 cases groups and the control group (Table 2). Among the 
controls, 6.5% (662/10,127) of mothers reported exposure to cold or flu with fever, and 
12.7% (1282/10,127) reported exposure to cold or flu without fever (Table 2). Among cases, 
the percent of mothers who reported exposure to cold or flu with fever ranged from 3.4% 
(3/89) for sacral agenesis to 18.0% (9/50) for colonic atresia/stenosis and the percent of 
mothers who reported exposure to cold or flu without fever ranged from 6.4% for bladder 
extrophy (4/62) to 16.1% for choanal atresia (23/143) (Table 2).
After adjustment for covariates, maternal cold or flu with fever during the exposure period 
was associated with statistically significant elevated odds ratios ranging from 1.23 to 3.68 
for 8 of the 30 birth defects that we studied (anencephaly, spina bifida, encephalocele, cleft 
lip with or without cleft palate, colonic atresia/stenosis, bilateral renal agenesis/hypoplasia, 
limb reduction defects, and gastroschisis) (Table 3). There were no statistically significant 
reduced risk aORs for maternal exposure to cold or flu with fever (Table 3). For mothers 
who reported a cold or flu without fever during the exposure period, none of the aORs 
indicated an elevated or reduced risk that was statistically significant (Table 3).
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Among women who reported a cold or flu with fever during the critical period, 40% 
reported that the maximum temperature of fever was ≥101 degrees Fahrenheit (F), 21% 
reported it was <101 degrees F and 39% did not answer the question. The aORs associated 
with maternal reports of cold or flu with fever ≥101 were not substantially different from the 
aORs associated with maternal report of cold or flu with fever < 101 (not shown).
For the first sensitivity analysis, we observed no statistically significant elevated aORs 
between maternal reports of cold or flu with fever during the 3rd or 4th month of pregnancy 
(61–120 days) and major noncardiac birth defects (Table 4). However, the aOR for duodenal 
atresia showed a statistically significant reduced risk (aOR = 0.35, 95% CI = 0.13, 0.94). 
(Table 4)
The sensitivity analysis restricted to isolated birth defects (i.e., excluding the case mothers 
who had infants with multiple birth defects or complex birth defects) resulted in findings 
consistent with those observed in the main analyses in Table 3 (not shown), with the 
exception of glaucoma/anterior chamber defects, for which a statistically significant 
association was observed for maternal report of a cold or flu without fever (aOR = 1.78, 
95% CI 1.12, 2.85).
The three additional sensitivity analyses resulted in findings very similar to those observed 
in Table 3 (not shown). In each of these three analyses, maternal report of cold or flu with 
fever during the critical gestational period was associated with statistically significant 
elevated aORs for the 8 birth defects described above with no additional significant findings.
6 | DISCUSSION
This study used data from the NBDPS to assess associations between (1) maternal exposure 
to a cold or flu with fever and (2) maternal exposure to cold or flu without fever and non-
cardiac birth defects. The large size of this population based database allowed us to study the 
association between these exposures and 30 noncardiac birth defects, including 20 birth 
defects for which this relationship had not yet been studied.
6.1 | Positive associations between cold or flu with fever and eight birth defects
We observed statistically significant associations between maternal report of cold or flu with 
fever during early pregnancy and offspring with gastroschisis and colonic atresia/stenosis 
that, to the best of our knowledge, have not been reported previously.
We also observed statistically significant associations between exposure to a cold or flu with 
fever during early pregnancy and six birth defects (anencephaly, spina bifida, encephalocele, 
cleft lip with or without cleft palate, limb reduction defects, and bilateral renal agenesis or 
renal hypoplasia), that have been reported in previous studies (Dreier et al., 2014; Moretti et 
al., 2005; Shaw et al., 2002). In addition, a study by Acs, Ba’nhidy, Puho’, and Czeizel 
(2005) reported associations for maternal fever and limb deficiencies and renal anomalies 
that were based on small numbers of exposed cases and did not achieve statistical 
significance.
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6.2 | No association between cold or flu with fever and 22 birth defects
Twenty-two of the 30 birth defects that we studied were not associated with exposure to 
maternal fever from a cold or flu in this study, that is, the aORs were not significantly above 
or significantly below 1.0. Previous studies addressed the possibility of an association 
between maternal fever and only 4 of these 22 birth defects (hydrocephaly, anorectal atresia, 
ear defects, and congenital cataracts) as described below.
Consistent with our results, two studies reported no statistically significant association 
between maternal fever during early pregnancy and hydrocephaly (Acs et al., 2005; Stoll, 
Alembik, Dott, & Roth, 1992).
In contrast with our results, two studies observed strong and significant associations between 
maternal fever and anorectal atresia (van Rooij et al., 2010; Wijers et al., 2010) with odds 
ratios based on only three and five exposed cases, respectively. In comparison, our study had 
56 exposed cases of anorectal atresia and we observed no statistically significant association 
between maternal fever from a cold or flu and this birth defect.
Only two previous studies, based on the Hungarian Case Control Surveillance of Congenital 
Anomalies, reported results that were both inconsistent with our findings and had adequate 
statistical power. These studies observed strong and statistically significant associations 
between maternal reports of influenza, cold or other respiratory illnesses during early 
pregnancy and isolated congenital anomalies of the ear, described as “mainly anotia or 
microtia” (Paput, Czeizel, & Ba’nhidy, 2011) and isolated congenital cataracts (Vogt, Puho’, 
& Czeizel, 2005). They did not include separate analyses for illnesses associated with or 
without a fever. Both of these studies and our own study included a large number of exposed 
cases and therefore low statistical power cannot explain the difference between our findings 
of no association between maternal cold or flu with fever and these two birth defects and the 
strong associations observed in these Hungarian studies.
6.3 | No associations between cold or flu without fever and 30 birth defects
The detailed questionnaire used by the NBDPS allowed us to make separate assessments of 
the effects of cold or flu with fever and cold or flu without fever. We observed no significant 
associations between cold or flu without fever and any of the 30 birth defects in this study. A 
similar distinction has been made by four of the previous studies (Abe, Honein, & Moore, 
2003; Botto et al., 2014; Hashmi, Gallaway, Waller, Langlois, & Hecht, 2010; Lynberg et al., 
1994). Studies of NTDs (Lynberg et al., 1994), renal anomalies (Abe et al., 2003) and 
previous NBDPS analyses of cardiac defects (Botto et al., 2014) and previous NBDPS 
analyses of oral clefts (Hashmi et al., 2010), observed no associations between cold or flu 
without illness and the birth defects they studied. This suggests that among mothers exposed 
to illnesses with fever, it may be fever that contributes to the excess risk of birth defect. 
However, it is possible that fever serves as a marker for infections that are more severe or 
due to specific microorganisms.
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6.4 | Recall bias
Similar to most of the previous case control studies, we measured the occurrence of fever 
due to cold or flu during pregnancy by maternal interviews conducted after delivery, 
introducing the possibility that, compared to control mothers, mothers of infants with birth 
defects may be more likely to recall a “cold or flu” or fever. However, in this analysis, 
significant associations were present only among mothers who were exposed to fever during 
the most relevant developmental period of early pregnancy and not for those who were 
exposed to fevers later during the 3rd or 4th month or pregnancy. Also, there were no 
statistically significant associations among mothers who were exposed to a cold or flu 
without a fever during early pregnancy.
In order for this pattern of results to be explained by differential recall bias, it would be 
necessary for the mothers in our study to have known that: (1) The first 8 weeks of gestation 
is the developmental period when most birth defects occur (Sadler, 2012) and (2) We 
postulated that a cold or flu with fever would be more likely to be associated with birth 
defects than a cold or flu without fever. We believe it is unlikely that the mothers in this 
study had this knowledge and therefore we think our findings are unlikely to be explained by 
differential recall bias. Additional evidence against the presence of differential recall of 
maternal fever is provided by a meta-analysis of the association between maternal fever 
during early pregnancy and offspring affected by NTDs in which the summary odds ratio for 
9 case control studies (OR = 1.93), was observed to be similar to the summary odds ratio for 
six cohort studies (OR = 1.95) (Moretti et al., 2005). As differential recall is not possible in 
cohort studies, the similarity of these results argues against it.
6.5 | Multiple statistical tests
We conducted many statistical tests and thus some of the statistically significant associations 
that we observed may be due to chance. As there is no biologically plausible reason for fever 
during the 3rd or 4th month of pregnancy to be associated with a reduced risk for duodenal 
atresia, it is likely that this result is due to chance. Assuming the null hypothesis, that 
maternal cold or flu with fever during early pregnancy is not associated with any of the 30 
birth defects that we studied, by chance alone we would most likely observe approximately 
one birth defect with a statistically significantly elevated aOR (30*0.05*0.5 = 0.75). 
However, 8 of the 30 birth defects that we studied had an aOR that was significantly elevated 
and for 6 of these birth defects (anencephaly, spina bifida, encephalocele, cleft lip with or 
without cleft palate, limb reduction defects, and bilateral renal agenesis) elevated odds ratios 
have been reported by previous studies. To the best of our knowledge, the elevated odds 
ratios that we observed for gastroschisis and colonic atresia have not been reported 
previously and therefore our findings for these two birth defects should be interpreted more 
cautiously until they are confirmed by future studies.
6.6 | Summary
We observed that report of a cold or flu accompanied by fever during early pregnancy was 
associated with 8 of the 30 categories of birth defects that we studied. Six of these birth 
defects have been found to be associated with maternal fever in previous studies and two of 
them have not been previously studied for this risk factor. We also addressed a gap present in 
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most of the previous studies regarding whether or not illness without fever is associated with 
birth defects, observing that cold or flu without fever was not associated with any of the 30 
categories of birth defects that we studied. This suggests that it may be fever that contributes 
to the excess risk of birth defect among mothers who have illnesses with fever. However, it is 
possible that fever serves as a marker for more severe infections.
Future research is needed to determine the role of fever, and whether use of antipyretic 
medication attenuates the associations we have observed. Women who are planning to 
become pregnant or have recently become pregnant should take measures to prevent 
themselves from developing an infection, particularly infections that may lead to a fever.
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TABLE 1
Characteristics of noncardiac cases of birth defects and controls, National Birth Defects Prevention Study, 
1997–2011
Cases Controls
Number Percent Number Percent
Total 17162 100.0 10127 100.00
Mother’s age (yrs)
 <18 623 3.6 327 3.2
 19–24 5415 31.6 2948 29.1
 25–29 4556 26.6 2815 27.8
 30–34 4041 23.6 2604 25.7
 35–39 2062 12.0 1192 11.7
 > 40 465 2.7 241 2.4
Mother’s race/ethnicity
 Non-Hispanic White 10324 60.2 6043 59.7
 Non-Hispanic Black 1665 9.7 1179 11.6
 Hispanic 3950 23.0 2222 21.9
 All others 1223 7.1 683 6.7
Mother’s educational level
 <High school 651 3.8 330 3.3
 Some high school 2078 12.1 1165 11.5
 Completed high school 4558 26.6 2417 23.9
 Some college 4796 28.0 2813 27.8
 ≥College graduate 5079 29.6 3402 33.6
Mother’s smoking statusa
 Yes 3665 21.4 1895 18.7
 No 13497 78.6 8232 81.3
First live birth
 Yes 7894 46.0 4112 40.6
 No 9268 54.0 6015 59.4
Mother’s BMIb(kg/m3)
 < 18.5 945 5.5 541 5.3
 18.5–24.9 8833 51.5 5406 53.4
 25.0–29.9 3903 22.7 2297 22.7
 ≥30.0 3481 20.3 1883 18.6
Mother’s use of supplements containing folic acidc
 Optimal 7967 46.4 4651 45.9
 Less than optimal 4603 26.8 2664 26.3
Birth Defects Res. Author manuscript; available in PMC 2019 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Waller et al. Page 12
Cases Controls
Number Percent Number Percent
 Inadequate 4592 26.8 2812 27.8
a
Maternal smoking between 1 month before conception and 3 months after conception.
b
BMI; body mass index.
cUse of supplements containing folic acid; optimal (daily intake between 1 month before conception and 1 month after conception), less than 
optimal (any intake between 1 month before conception and 1 month after conception) and inadequate (intake of folic acid beginning later than 1 
month after conception or never).
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TABLE 2
Percent of mothers reporting cold or flu with fever or cold or flu without fever during the periconceptional 
perioda, National Birth Defects Prevention Study, 1997–2011
Mother reported cold or flu with fever Mother reported cold or flu with fever
Percentage Exposed/total Percentage Exposed/total
Controlsb 6.5% 662/10127 12.7% 1282/10127
Anencephaly 9.0% 50/553 15.0% 83/553
Spina bifida 8.8% 93/1053 13.8% 145/1053
Encephalocele 9.5% 18/190 13.2% 25/190
Dandy-Walker 6.3% 10/159 15.1% 24/159
Holoprosencephaly 8.1% 12/148 10.8% 16/148
Hydrocephaly 5.9% 26/440 14.1% 62/440
Anophthalmos/microphthalmos 7.0% 14/201 9.0% 18/201
Glaucoma/anterior chamber defects 7.7% 12/155 15.4% 24/155
Congenital cataract 7.3% 25/341 13.4% 46/341
Anotia/microtia 5.9% 33/555 11.9% 66/555
Choanal atresia 7.7% 11/143 16.1% 23/143
Cleft palate alone 6.6% 92/1386 13.6% 189/1386
Cleft lip with or without cleft palate 8.0% 215/2700 12.1% 327/2700
Oesophageal atresia/stenosis 6.4% 42/657 12.3% 81/657
Intestinal atresia/stenosis 8.1% 33/409 12.4% 51/409
Duodenal atresia/stenosis 7.4% 15/202 10.9% 22/202
Colonic atresia/stenosis 18.0% 9/50 10.0% 5/50
Anorectal atresia/stenosis 6.1% 56/922 12.9% 119/922
Biliary atresia/stenosis 4.1% 7/170 11.8% 20/170
Hypospadias 6.1% 134/2211 12.3% 271/2211
Bilateral renal agenesis/hypoplasia 12.3% 19/154 13.6% 21/154
Bladder extrophy 8.1% 5/62 6.4% 4/62
Cloacal extrophy 8.5% 7/82 14.6% 12/82
Limb reduction defects 8.0% 86/1078 13.4% 144/1078
Craniosynostosis 6.5% 88/1349 13.0% 175/1349
Diaphragmatic hernia 6.8% 50/737 11.8% 87/737
Omphalocele 6.8% 26/380 15.0% 57/380
Gastroschisis 8.1% 100/1239 12.3% 153/1239
Amniotic band syndrome 7.9% 23/292 11.3% 33/292
Sacral agenesis 3.4% 3/89 11.2% 10/89
a
Period from 30 days prior to conception to 60 days after conception.
b
For some defects the number of controls is less than the number shown here because of adjustments for differences in ascertainment of those birth 
defects. Percentages calculated after all exclusions.
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TABLE 3
Adjusted associationsa between maternal reports of cold or flu with fever and cold or flu without fever during 
the periconceptional periodb and major birth defects, the National Birth Defects Prevention Study, 1997–2011
Report of cold or flu with fever Report of cold or flu without fever
aORc 95% CId aORc 95% CId
Anencephaly 1.52 (1.11, 2.07) 1.25 (0.98, 1.60)
Spina bifida 1.39 (1.11, 1.76) 1.13 (0.93, 1.36)
Encephalocele 1.66 (1.01, 2.74) 1.17 (0.76, 1.80)
Dandy-Walker 1.11 (0.58, 2.13) 1.31 (0.84, 2.04)
Holoprosencephaly 1.32 (0.72, 2.42) 0.94 (0.55, 1.59)
Hydrocephaly 0.94 (0.63, 1.42) 1.14 (0.86, 1.50)
Anophthalmos/microphthalmos 1.04 (0.60, 1.81) 0.70 (0.43, 1.15)
Glaucoma/anterior chamber defects 1.37 (0.75, 2.50) 1.39 (0.89, 2.17)
Congenital cataract 1.23 (0.81, 1.88) 1.12 (0.81, 1.54)
Anotia/microtia 0.96 (0.66, 1.38) 1.01 (0.77, 1.32)
Choanal atresia 1.17 (0.62, 2.20) 1.34 (0.84, 2.11)
Cleft palate alone 1.00 (0.80, 1.26) 1.09 (0.93, 1.29)
Cleft lip w/wo cleft palate 1.23 (1.05, 1.45) 0.97 (0.85, 1.10)
Oesophageal atresia/stenosis 0.98 (0.71, 1.37) 0.99 (0.78, 1.26)
Intestinal atresia/stenosis 1.33 (0.92, 1.82) 1.05 (0.77, 1.42)
Duodenal atresia/stenosis 1.27 (0.74, 2.17) 0.89 (0.56, 1.39)
Colonic atresia/stenosis 3.68 (1.72, 7.85) 0.96 (0.37, 2.48)
Anorectal atresia/stenosis 0.95 (0.72, 1.27) 1.07 (0.87, 1.31)
Biliary atresia/stenosis 0.64 (0.30, 1.39) 0.93 (0.58, 1.49)
Hypospadias 1.01 (0.81, 1.25) 0.99 (0.84, 1.16)
Bilateral renal agenesis/hypoplasia 2.10 (1.28, 3.46) 1.21 (0.76, 1.95)
Bladder extrophy 1.11 (0.44, 2.82) 0.48 (0.17, 1.33)
Cloacal extrophy 1.40 (0.64, 3.09) 1.25 (0.67, 2.32)
Limb reduction defects 1.29 (1.01, 1.63) 1.11 (0.92, 1.34)
Craniosynostosis 0.91 (0.72, 1.16) 0.97 (0.82, 1.15)
Diaphragmatic hernia 1.04 (0.77, 1.41) 0.94 (0.74, 1.18)
Omphalocele 1.21 (0.80, 1.82) 1.32 (0.99, 1.77)
Gastroschisis 1.42 (1.11, 1.81) 1.06 (0.87, 1.29)
Amniotic band syndrome 1.37 (0.88, 2.14) 0.92 (0.63, 1.34)
Sacral agenesis 0.48 (0.15, 1.53) 0.86 (0.44, 1.66)
aAdjusted for maternal age, race, educational level, first birth, body mass index, study site and smoking and folic acid intake during the 
periconceptional period.
b
Period from 30 days prior to conception to 60 days after conception.
c
aOR: Adjusted odds ratio.
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d95% CI: 95% confidence interval.
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TABLE 4
Adjusteda associations between maternal report of cold or flu with fever in the 3rd or 4th month of pregnancy 
and major birth defects, National Birth Defects Prevention Study, 1997–2011
aORb 95% CIc
Anencephaly 0.72 (0.47, 1.10)
Spina bifida 1.01 (0.77, 1.32)
Encephalocele 1.16 (0.64, 2.10)
Dandy-Walker 0.83 (0.38, 1.78)
Holoprosencephaly 0.69 (0.30, 1.58)
Hydrocephaly 0.69 (0.43, 1.12)
Anophthalmos/microphthalmos 0.96 (0.51, 1.78)
Glaucoma/anterior chamber defects 0.73 (0.32, 1.67)
Congenital cataract 1.26 (0.81, 1.96)
Anotia/microtia 1.15 (0.81, 1.64)
Choanal atresia 0.81 (0.37, 1.75)
Cleft palate alone 1.05 (0.83, 1.33)
Cleft lip w/wo cleft palate 0.86 (0.71, 1.04)
Oesophageal atresia/stenosis 0.95 (0.67, 1.33)
Intestinal atresia/stenosis 1.19 (0.80, 1.78)
Duodenal atresia/stenosis 0.35 (0.13, 0.94)
Colonic atresia/stenosis 1.00 (0.30, 3.27)
Anorectal atresia/stenosis 0.94 (0.70, 1.27)
Biliary atresia/stenosis 0.59 (0.26, 1.34)
Hypospadias 0.96 (0.76, 1.20)
Bilateral renal agenesis/hypoplasia 1.02 (0.53, 1.96)
Bladder extrophy 0.95 (0.34, 2.66)
Cloacal extrophy 0.59 (0.19, 1.89)
Limb reduction defects 1.09 (0.84, 1.42)
Craniosynostosis 0.95 (0.75, 1.21)
Diaphragmatic hernia 0.84 (0.59, 1.18)
Omphalocele 1.04 (0.67, 1.62)
Gastroschisis 0.98 (0.74, 1.29)
Amniotic Band Syndrome 1.47 (0.94, 2.29)
Sacral agenesis 0.93 (0.37, 2.31)
aAdjusted for maternal age, race, educational level, first birth, body mass index, study site and smoking and folic acid intake during the 
periconceptional period.
b
aOR: Adjusted odds ratio.
c95% CI: 95% confidence interval.
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